Bio Clinical Collection of Urothelial Carcinoma

Launched by UNIVERSITY HOSPITAL, TOULOUSE · Jul 20, 2021

Keywords

ClinConnect Summary

This clinical trial, called the Bio Clinical Collection of Urothelial Carcinoma, is focused on gathering important samples from patients who have bladder cancer, also known as urothelial carcinoma. Researchers will collect tumor samples, as well as urine, stool, and blood from participants. These samples will be kept safe and private at the Toulouse University Hospital. The goal is to better understand this type of cancer and improve future treatments.

If you are an adult over 18 years old and have been diagnosed with or are suspected to have bladder cancer, you may be eligible to participate in this study. To join, you need to be willing to give your consent for the study. However, pregnant or breastfeeding women, individuals under 18, and those unable to consent for themselves cannot participate. If you decide to join, you will help advance research that could benefit others facing this disease in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adult \>18 years old
• • Patient with suspected or diagnosed Urothelial carcinoma
• • Patients who are willing to consent for this protocol.
• Exclusion Criteria:
• • Pregnant or breastfeeding patients
• • Patients under 18 years old
• • Patients under guardianship or curators
• • Patients unable to sign a free and informed consent